![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SIRION THERAPEUTICS SETS ITS SIGHTS ON OPHTHALMIC HEALTH
SIRION THERAPEUTICS SETS ITS SIGHTS ON OPHTHALMIC HEALTH
June 19, 2006
Founded with a mission to protect and preserve the gift of sight, executives from the newly created Sirion Therapeutics, Inc. unveiled their new company today. The announcement was made by co-founders Barry Butler, Chairman and Chief Executive Officer; Roger
Vogel, MD, Chief Medical Officer; Susan Benton, Chief Commercial Officer; and
Philippe Boulangeat, Chief Business Officer.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct